Clinical Trials Logo

Smoking Cessation clinical trials

View clinical trials related to Smoking Cessation.

Filter by:

NCT ID: NCT03439553 Completed - Obesity Clinical Trials

Estimating the Short-term Effectiveness of Online Advertisements for Improving Health

Start date: April 16, 2015
Phase: N/A
Study type: Interventional

Bing ads designed to encourage people to adopt healthier practices (e.g., stop smoking, become physically active, stop consuming harmful content) are shown using the advertising system, to test which ads are more effective as apparent in the subsequent queries to Bing submitted by users who saw the ads.

NCT ID: NCT03432312 Completed - Smoking Cessation Clinical Trials

Single-Dose Bioequivalence Study Comparing Two 4 mg Nicotine Lozenges

Start date: January 15, 2018
Phase: Phase 1
Study type: Interventional

The purpose of the study is to compare the pharmacokinetic (PK) profiles and assess bioequivalence between a new nicotine lozenge and a reference nicotine lozenge in healthy smokers

NCT ID: NCT03432273 Completed - Smoking Cessation Clinical Trials

Single-Dose Bioequivalence Study Comparing Two 2 mg Nicotine Lozenges

Start date: February 19, 2018
Phase: Phase 1
Study type: Interventional

The purpose of the study is to compare the pharmacokinetic (PK) profiles and assess bioequivalence between a new nicotine lozenge and a reference nicotine lozenge in healthy smokers.

NCT ID: NCT03431324 Not yet recruiting - Smoking Cessation Clinical Trials

Mating-EFT Smoking Cessation Intervention

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

The current proposal aims to develop and establish the effectiveness of a novel behavioral smoking cessation intervention. Previous research has shown that having smokers engage in episodic future thinking (EFT) about specific positive life outcomes that they could experience if they quit smoking immediately can be an effective means of reducing cigarette consumption. This intervention allowed participants to generate their own general positive life outcomes. While the existing intervention approaches motivation from a generalist perspective, the current proposal seeks to modify this intervention to fit within a Fundamental Social Motives (FSM) framework. The FSM framework posits that there exist individual differences in fundamental social motives such as self-protection, disease avoidance, affiliation, kin care, and mating motives such that some individuals are more motivated to work toward some of these goals than others. Specifically, the current proposal seeks to develop an EFT intervention that appeals to fundamental mating motives by asking participants to imagine positive mating outcomes that they might experience in one year's time if they were to quit smoking immediately. This will be accomplished via two empirical studies. Study 1 will compare the effectiveness of the mating-EFT intervention to the general-EFT intervention and a yoked control condition while examining the possibility that individual differences in relationship status, mating motives, self-efficacy, and nicotine dependence moderate these effects. Study 2 will employ a quasi-experimental design to test the effectiveness of this intervention using a tailored messaging approach, assigning smokers who are either single and motivated to seek new mates or involved in a committed relationship and not motivated to seek new mates to complete the general or mating-EFT or a control task. The investigators predict that the mating-EFT will be more effective than the general EFT in reducing cigarette consumption, particularly if it is administered to participants who have more active mating goals.

NCT ID: NCT03426423 Terminated - Smoking Cessation Clinical Trials

Diabetes and Smoking Cessation: a Gender-Oriented Study

DiSCGO
Start date: March 1, 2018
Phase: N/A
Study type: Interventional

People with diabetes still smoke at equivalent rates as non-diabetics. There is lack of evidence regarding interventions for smoking cessation among individuals with diabetes. The aim of this project is to assess the 12 months efficacy of a smoking cessation intervention tailored to diabetes and gender specificities, in a population of 500 smokers with type 2 diabetes. The secondary objectives are to assess the impact of smoking cessation on anthropometric outcomes, diabetes control and renal function and fecal microbiota.

NCT ID: NCT03405220 Active, not recruiting - Smoking Cessation Clinical Trials

Testing a Self-affirmation Intervention for Use in a Mobile Application

Start date: January 16, 2018
Phase: N/A
Study type: Interventional

The aim of these studies is to adapt the self-affirmation kindness questionnaire for use in a mobile application. Two studies will be conducted to test hypotheses that simplifying and shortening the original questionnaire in systematic ways will result in comparable effectiveness (compared to the original version) in promoting reduced defensive avoidance, less reactance, greater yielding, and higher intentions to quit smoking among a sample of smokers.

NCT ID: NCT03405129 Completed - Smoking Cessation Clinical Trials

Project Phoenix: Pilot Intervention for Smokers Who Are Not Ready to Quit Smoking

Phoenix
Start date: October 17, 2018
Phase: N/A
Study type: Interventional

Smoking is the leading preventable cause of death and disease in the United States. Although most smokers report that they would like to quit smoking at some point in the future, only 20% are ready to quit within the next 30 days. Importantly, studies have indicated that interventions can increase motivation and/or readiness for cessation among smokers who are not yet ready to quit and these types of intervention can increase smoking cessation attempts. Smartphone apps that offer daily information about the benefits of quitting and motivational/supportive messages that aim to increase cessation self-efficacy may increase the likelihood of initiating a smoking cessation attempt. Previous research has indicated that smoking cessation smartphone applications are feasible and well-liked by smokers who are already committed to quitting smoking. However, there are no empirically supported smartphone apps that provide dynamic smoking cessation content that is automatically matched to a smoker's current readiness to quit. This type of dynamically tailored intervention could overcome many of the barriers that have hampered the widespread use of traditional empirically supported smoking cessation treatments. The current pilot study (N=150) is a 3-armed randomized controlled smoking cessation induction trial that will determine the initial utility of a novel smartphone based intervention compared with an attention control group among smokers who are not yet ready to quit. The two intervention groups (Group 1: Phoenix App Only; Group 2: Phoenix App + Nicotine Replacement Therapy [NRT]) will receive targeted smoking cessation messaging that is matched to a participant's readiness to quit, while the attention control group (i.e., Factoid) will receive messages that are not related to smoking cessation.

NCT ID: NCT03404596 Completed - Smoking Cessation Clinical Trials

Applying mHealth to Tobacco-related Health Disparities

Time2Quit
Start date: July 16, 2018
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to better understand what happens when someone attempts to quit smoking.

NCT ID: NCT03401021 Completed - Smoking Cessation Clinical Trials

Factors Related to the Intention to Quit Among Male Smokers During Their Wives Pregnancy

Start date: December 6, 2017
Phase:
Study type: Observational

This study aims to use a cross-sectional study and semi-structured interview to explore the level of intention to quit smoking among male smokers whose partner got pregnant and further explore factors associated with their quit intention.

NCT ID: NCT03397511 Completed - Smoking Cessation Clinical Trials

Incorporating Financial Incentives to Increase Smoking Cessation Among Asian Americans Residing in New York City

Start date: September 5, 2018
Phase: N/A
Study type: Interventional

Financial incentives for motivating health change have been increasingly employed in various healthcare sectors. They can be a potentially effective approach to promote smoking behavioral change and increase the use of evidence-based counseling and pharmacotherapy. Smoking cessation randomized clinical trials (RCT) incorporating financial incentives have been conducted in different populations; however, there has not been a randomized clinical trial coupled with a financial incentive with Asian American cigarette smokers. The purpose of this pilot study is to examine the feasibility of implementing an incentivized smoking cessation program among Asian American smokers in New York City.